Evidence map›Paper›PMID 41721087›Full record

ArticleLeukemia2026

The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1.

Khalid Shoumariyeh, Stefan Haug, Juliana Schwaab, Julie K Pfeil, Jannis Stappenbeck, Annette Schmitt-Graeff, Nicole Naumann, Greta Waltemode, Robert Zeiser, Cornelius Miething and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Khalid ShoumariyehDepartment of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. khalid.shoumariyeh@uniklinik-freiburg.de.ORCID http://orcid.org/0000-0001-7969-1972
Stefan HaugInstitute of Epidemiology and Prevention, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany.
Juliana SchwaabUniversity Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Julie K PfeilGerman Cancer Consortium (DKTK), Partner Site Freiburg, a partnership between DKFZ and University Medical Center Freiburg, Freiburg, Germany.ORCID http://orcid.org/0009-0001-1015-5052
Jannis StappenbeckDivision of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Annette Schmitt-GraeffUniversity of Freiburg, Freiburg, Germany.
Nicole NaumannUniversity Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Greta WaltemodeDepartment of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Robert ZeiserDepartment of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0001-6565-3393
Cornelius MiethingDepartment of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0003-4699-3805
Wolf-Karsten HofmannUniversity Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Manja MeggendorferMLL Munich Leukemia Laboratory, Munich, Germany.ORCID http://orcid.org/0000-0002-9038-3265
Sven DiederichsGerman Cancer Consortium (DKTK), Partner Site Freiburg, a partnership between DKFZ and University Medical Center Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0001-7901-4752
Justus DuysterDepartment of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0001-7325-7753
Andreas ReiterUniversity Hospital Mannheim, Heidelberg University, Mannheim, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41721087
PMCPMC13056580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.